Skip to main content

INTREPID FAMILY OFFICE LLC

Family Office

Position in ORGO — Organogenesis Holdings Inc.

CIK 1596197 SARASOTA, FL

Position in ORGO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$110,200
-$64,184 QoQ
Shares Held
45,350
-38.4% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#60
of 135 holders
Holding Since
Sep 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ORGO Over Time

Shares Held

Position Value (USD)

Derivatives in ORGO

reported options exposure · as of Sep 30, 2023
CallValue
$79,500
CallShares
25,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

INTREPID FAMILY OFFICE LLC holds $110,200 across 1 Drug Manufacturers - Specialty & Generic name. ORGO ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ORGO
Organogenesis Holdings Inc.
This page
45,350 $110,200

All Filings in ORGO

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $110,200 45,350
2026-03-31 $174,384 73,580
2025-12-31 $518,000 100,000
2025-09-30 $338,022 80,100
2025-06-30 $402,600 110,000
2025-03-31 $432,000 100,000
2024-12-31 $336,000 105,000
2023-09-30 $318,000 100,000
2023-09-30 $79,500 25,000
2023-06-30 $365,200 110,000
2023-03-31 $85,200 40,000
2022-12-31 $107,600 40,000
2022-09-30 $113,400 35,000